Patient Safety Organizations: Voluntary Relinquishment for the American Physician Partners, LLC PSO, 53487-53488 [2023-16895]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 151 / Tuesday, August 8, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
(hereafter Lynden LPOE), approximately
10 miles west of the Sumas LPOE at the
end of Route 539 at the U.S.-Canada
border. The Lynden LPOE is an
inspection facility where U.S. Customs
and Border Protection (CBP) processes
personal vehicles, buses, limited
commercial vehicles (permit only), and
pedestrian traffic. There are four
primary non-commercial lanes, one of
which can also process limited
commercial traffic. The port was
constructed in 1988 and operates 16
hours a day, seven days a week.
The Sumas LPOE is an inspection
facility where CBP processes
commercial vehicles, personal vehicles,
and pedestrian traffic at the U.S.-Canada
border at 103 Cherry St, Sumas, WA
98295. There are currently four primary
non-commercial lanes, with three lanes
that process personal vehicles and one
that accommodates buses and oversized
vehicles; and two primary commercial
lanes with booths. Pedestrian traffic
transits through indoor processing
queues and spaces. The port was
constructed in 1988 and operates 24
hours a day, seven days a week.
The current Lynden and Sumas
LPOEs no longer function adequately
and cannot meet current operational
needs. At the Lynden LPOE, space
limitations cause frequent congestion in
the commercial lane and commercial
vehicles often travel farther distances to
other ports that offer more efficient
processing. The Sumas LPOE does not
have enough space for efficient traffic
flow or safe and secure inspection areas,
which impede the port’s operations and
cause traffic and safety concerns in the
surrounding urban area.
Alternatives Under Consideration
The EIS will evaluate a total of four
alternatives at each location—one ‘‘no
action’’ or ‘‘no build’’ alternative and
three ‘‘action’’ or ‘‘build’’ alternatives.
Alternative 1 is the No Action
Alternative, which assumes that any
demolition of existing facilities,
construction of new facilities, and
expansion of LPOE operations would
not occur. Both LPOEs would continue
to operate under current conditions. The
three action alternatives would improve
the efficiency and effectiveness of the
Lynden and Sumas LPOEs and would
all include acquiring land, demolishing
existing facilities, and constructing new
facilities.
At the Lynden LPOE, Alternative 2
would include an east-west facility
layout for commercial inspections.
Alternative 3 would be identical to
Alternative 2 other than the rotation of
commercial inspection to a north-south
orientation. Land acquisition under
VerDate Sep<11>2014
20:00 Aug 07, 2023
Jkt 259001
Alternatives 2 and 3 at the Lynden
LPOE would be similar in acreage but
would differ in location or orientation.
Alternative 4 would consist of the same
facility layout as either Alternative 2 or
3, but would alter construction phasing
such that construction activities at the
LPOEs occur sequentially. Under
Alternative 4, the Lynden LPOE would
close and construction activities at the
Lynden LPOE would occur first. Once
the Lynden LPOE is reopened, the
Sumas LPOE would close and
construction activities at the Sumas
LPOE would occur.
At the Sumas LPOE, the layout of
Alternative 2 is designed to optimize
operational flow—especially for
outbound non-commercial vehicles. The
facility layout of Alternative 3
maximizes the vehicle maneuvering
area (especially for larger vehicles like
trucks). Alternative 4 consists of a
multiple story construction in order to
provide greater vehicle maneuvering
area for transiting vehicles. Compared to
Alternatives 2 and 3, Alternative 4
would not have a different number of
commercial, outbound, or personal
vehicle lanes, but it may consolidate
some of the administrative buildings
and have a slightly smaller overall
footprint. Land acquisition at the Sumas
LPOE would be identical under each
alternative.
Demolition, construction, and
renovation activities would be phased to
maintain LPOE operations at both ports
for the entirety of the construction
period under all action alternatives—
except for Alternative 4 at the Lynden
LPOE, which would require closing
operations at both LPOEs during their
respective construction activities.
During this time, traffic at the LPOE
under construction would be directed to
the operational LPOE.
Potential impacts from these three
action alternatives will be compared
against a first ‘‘no action’’ alternative
wherein the current LPOE facilities
would continue to operate under
existing conditions. The EIS will
address the potential environmental
impacts of the proposed alternatives on
resource areas including but not limited
to land use, water resources (including
floodplains), biological resources,
geology and soils, transportation and
traffic, noise, cultural and Tribal
resources, socioeconomics,
environmental justice and protection of
children’s health, hazardous waste and
PO 00000
materials, air quality, climate change,
and utilities.
Anamarie T. Crawley,
Director, GSA–PBS R10 Facilities
Management Division.
[FR Doc. 2023–16957 Filed 8–7–23; 8:45 am]
BILLING CODE 6820–DL–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment for the
American Physician Partners, LLC
PSO
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
AGENCY:
ACTION:
Notice of delisting.
The Patient Safety and
Quality Improvement Final Rule
(Patient Safety Rule) authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a patient safety organization (PSO) an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient
Safety Rule, when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason, or when a PSO’s
listing expires. AHRQ accepted a
notification of proposed voluntary
relinquishment from the American
Physician Partners, LLC PSO, PSO
number P0223, of its status as a PSO,
and has delisted the PSO accordingly.
SUMMARY:
The delisting was effective at
12:00 Midnight ET (2400) on July 31,
2023.
DATES:
The directories for both
listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. Both
directories can be accessed
electronically at the following HHS
website: https://www.pso.ahrq.gov/listed.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, MS 06N66B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Frm 00037
Fmt 4703
Sfmt 4703
53487
E:\FR\FM\08AUN1.SGM
08AUN1
53488
Federal Register / Vol. 88, No. 151 / Tuesday, August 8, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Background
The Patient Safety Act, 42 U.S.C.
299b–21 to 299b–26, and the related
Patient Safety Rule, 42 CFR part 3,
published in the Federal Register on
November 21, 2008 (73 FR 70732–
70814), establish a framework by which
individuals and entities that meet the
definition of provider in the Patient
Safety Rule may voluntarily report
information to PSOs listed by AHRQ, on
a privileged and confidential basis, for
the aggregation and analysis of patient
safety work product.
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
PSOs.
AHRQ has accepted a notification of
proposed voluntary relinquishment
from the American Physician Partners,
LLC PSO to voluntarily relinquish its
status as a PSO. Accordingly, the
American Physician Partners, LLC PSO,
P0223, was delisted effective at 12:00
Midnight ET (2400) on July 31, 2023.
American Physician Partners, LLC
PSO has patient safety work product
(PSWP) in its possession. The PSO will
meet the requirements of section
3.108(c)(2)(i) of the Patient Safety Rule
regarding notification to providers that
have reported to the PSO and of section
3.108(c)(2)(ii) regarding disposition of
PSWP consistent with section
3.108(b)(3). According to section
3.108(b)(3) of the Patient Safety Rule,
the PSO has 90 days from the effective
date of delisting and revocation to
complete the disposition of PSWP that
is currently in the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO website
at https://www.pso.ahrq.gov.
VerDate Sep<11>2014
20:00 Aug 07, 2023
Jkt 259001
Dated: August 2, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–16895 Filed 8–7–23; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[Docket No. ATSDR–2023–0003]
Nominations for Substances To Be
Evaluated for Toxicological Profile
Development
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
(ATSDR), within the Department of
Health and Human Services (HHS),
announces that it is soliciting
nominations of substances to be
evaluated for an upcoming set of
toxicological profiles. ATSDR is
opening a docket for the public to
submit nominations and provide
comment on which toxicological
profiles are developed next. Members of
the public, government agencies, or
private organizations may comment on
which substances they are concerned
about so that ATSDR may take this
information into consideration when
developing future toxicological profiles.
DATES: Written nominations and
comments must be received by
September 7, 2023.
ADDRESSES: You may submit
nominations, identified by Docket No.
ATSDR–2023–0003, by either of the
methods listed below. Do not submit
comments by email. ATSDR does not
accept comments by email.
• Federal eRulemaking Portal at
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Agency for Toxic Substances
and Disease Registry, Office of
Innovation and Analytics, 4770 Buford
Highway, Mail Stop S106–5, Atlanta,
GA 30341–3717. Attn: Docket No.
ATSDR–2023–0003.
Instructions: All submissions must
include the agency name and docket
number for this notice. All relevant
comments will be posted without
change to https://www.regulations.gov,
including any personal information
provided. Refer to the Submission of
Nominations section (below) for the
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
specific information required to be
included in a nomination. For access to
the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Farhana Rahman, Agency for Toxic
Substances and Disease Registry, Office
of Innovation and Analytics, 1600
Clifton Rd. NE, Mail Stop S106–5,
Atlanta, GA 30329–4027; Email:
ATSDRToxProfileFRNs@cdc.gov; Phone:
1–800–232–4636.
SUPPLEMENTARY INFORMATION: The
Superfund Amendments and
Reauthorization Act of 1986 (SARA) [42
U.S.C. 9601 et seq.] amended the
Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERCLA or Superfund) [42
U.S.C. 9601 et seq.] by establishing
certain requirements for ATSDR and the
U.S. Environmental Protection Agency
(EPA) concerning hazardous substances
most commonly found at facilities on
the CERCLA National Priorities List
(NPL). Among these statutory
requirements is a mandate for the
Administrator of ATSDR to prepare
toxicological profiles for each substance
included on the Priority List of
Hazardous Substances, also known as
the Substance Priority list (SPL). This
list identifies 275 hazardous substances
found at NPL sites that ATSDR has
determined currently pose the most
significant potential threat to human
health. For more information on
ATSDR’s SPL, visit https://
www.atsdr.cdc.gov/SPL/.
Substances to be Evaluated for
Toxicological Profile Development
Each year, ATSDR develops a list of
substances to be considered for
toxicological profile development. The
nomination process includes
consideration of all substances on
ATSDR’s SPL, as well as other
substances nominated by the public.
Submission of Nominations for
Toxicological Profile Development
This notice invites public
nominations of substances for
toxicological profile development. If
nominating a substance that is not on
the SPL, please include the rationale for
the nomination and any supporting
data. ATSDR will evaluate data and
information associated with nominated
substances and will determine the final
list of substances to be chosen for
toxicological profile development.
Public Participation
Interested persons or organizations
are invited to participate by submitting
nominations for substances. These
E:\FR\FM\08AUN1.SGM
08AUN1
]]>Agencies
[Federal Register Volume 88, Number 151 (Tuesday, August 8, 2023)]
[Notices]
[Pages 53487-53488]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16895]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment for the
American Physician Partners, LLC PSO
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient
Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to
list as a patient safety organization (PSO) an entity that attests that
it meets the statutory and regulatory requirements for listing. A PSO
can be ``delisted'' by the Secretary if it is found to no longer meet
the requirements of the Patient Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses
to voluntarily relinquish its status as a PSO for any reason, or when a
PSO's listing expires. AHRQ accepted a notification of proposed
voluntary relinquishment from the American Physician Partners, LLC PSO,
PSO number P0223, of its status as a PSO, and has delisted the PSO
accordingly.
DATES: The delisting was effective at 12:00 Midnight ET (2400) on July
31, 2023.
ADDRESSES: The directories for both listed and delisted PSOs are
ongoing and reviewed weekly by AHRQ. Both directories can be accessed
electronically at the following HHS website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N66B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
(301) 427-1130; Email: [email protected].
SUPPLEMENTARY INFORMATION:
[[Page 53488]]
Background
The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the
related Patient Safety Rule, 42 CFR part 3, published in the Federal
Register on November 21, 2008 (73 FR 70732-70814), establish a
framework by which individuals and entities that meet the definition of
provider in the Patient Safety Rule may voluntarily report information
to PSOs listed by AHRQ, on a privileged and confidential basis, for the
aggregation and analysis of patient safety work product.
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of PSOs.
AHRQ has accepted a notification of proposed voluntary
relinquishment from the American Physician Partners, LLC PSO to
voluntarily relinquish its status as a PSO. Accordingly, the American
Physician Partners, LLC PSO, P0223, was delisted effective at 12:00
Midnight ET (2400) on July 31, 2023.
American Physician Partners, LLC PSO has patient safety work
product (PSWP) in its possession. The PSO will meet the requirements of
section 3.108(c)(2)(i) of the Patient Safety Rule regarding
notification to providers that have reported to the PSO and of section
3.108(c)(2)(ii) regarding disposition of PSWP consistent with section
3.108(b)(3). According to section 3.108(b)(3) of the Patient Safety
Rule, the PSO has 90 days from the effective date of delisting and
revocation to complete the disposition of PSWP that is currently in the
PSO's possession.
More information on PSOs can be obtained through AHRQ's PSO website
at https://www.pso.ahrq.gov.
Dated: August 2, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-16895 Filed 8-7-23; 8:45 am]
BILLING CODE 4160-90-P
